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Summary. Coeliac disease is associated with intestinal 
lesion. This lesion causes architectural derangement of 
the mucosa in the form of villus atrophy, increased crypt 
length and increased volume of the lamina propria. 
Several changes in the intestinal endocrine cells have 
been reported over the years, e.g. the number of secretin 
cells and increased numbers of GIP, CCKIgastrin, 
motilin, and serotonin cells. There is no consensus about 
the nature of the changes in somatostatin-cells. It has 
been postulated that the changes in the endocrine cells 
are a selective process to meet the new demands exerted 
by the dramatic decrease in intestinal absorptive area. It 
has been speculated further that the changes in the 
endocrine cells would cause an incomplete digestion of 
the ingested food and its rapid elimination from the 
intestine. These changes may be responsible for the 
diarrhoea and steatorrhoea that occur in patients with 
coeliac disease. 
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Introduction 
The first description of coeliac disease is attributed 
to Aretaeus, who lived in the first or second century AD 
(Major, 1945). In 1888, Samuel Gee described the 
features of the condition with remarkable accuracy and 
even suggested that a cure might be found in the diet 
(Gee, 1888). It was not until 1954, however, that the 
characteristic intestinal lesion was described by Paulley 
(1954). The prevalence of this disease in adults, based 
on detected symptomatic cases, has been reported to be 
1:950 in Sweden (Hallert et al., 1983) and 1:1700 in 
Scotland (Logan et al., 1986). The true prevalence of 
coeliac disease is believed to be much greater, viz. close 
to a rate of 1 in 300 in the general population (Auricchio 
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et al., 1990). In Swedish children its prevalence was 
estimated by Berg and Lindberg (1979) to be 1:982. The 
sex frequency is almost evenly balanced in childhood 
(Corazza and Gasbarrini, 1995), whereas in adults the 
fema1e:male ratio is 2:l (Howdle and Losowsky, 1992). 
Coeliac disease has an extraordinary breadth of 
manifestations and many cases are unrecognised or 
latent (Duggan, 1997). Coeliac disease is accompanied 
by malabsorption of minerals, vitamins, carbohydrates 
and fat (Sjolund, 1982). The clinical manifestations of 
the disease are alike in juvenile and adult form. 
Diarrhoea, weight loss, abdominal destination and pain, 
cramp or tetany and oedema are common symptoms in 
patients with coeliac disease (Corazza and Gasbarrini, 
1995; Littlewood, 1995). In juvenile form, slow 
development also occurs (Littlewood, 1995). 
The small-intestinal lesion of coeliac disease results 
in architectural derangement of the mucosa and changes 
in several endocrine cells. These cells play an important 
role in the regulation of several functions of the gut, 
such as motility and secretion ( H a ~ e y ,  1975; Allescher 
and Ahmed, 1991; Ekblad et al., 1991; Dockray and 
Walsh, 1994). It is conceivable, therefore, that these 
changes may be involved in the pathogenesis of the 
disease and its clinical manifestation. The nature and 
types of endocrine cell affected are debatable, however. 
In the present review, a survey of the changes in the 
intestinal endocrine cells of patients with coeliac disease 
is presented. The nature of these changes is discussed, 
and their pathophysiological role and clinical 
implications are speculated upon. 
Mucosal architecture changes 
The mucosa of small intestine in untreated coeliac 
disease shows an architectural derangement in the form 
of villus atrophy and increased crypt length (Wright et 
al., 1973a,b; Watson et al., 1980). These abnormalities 
are a result of damage to villus enterocytes (Booth, 
1970; Perera et al., 1975; Wastson et al., 1980) and a 
compensatory increase in crypt cell proliferation and 
production rate (Booth, 1970; Wright et al., 1973a,b; 
Perera et al., 1975; Watson et al., 1980). The mean 






